Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,914.00
Bid: 10,918.00
Ask: 10,922.00
Change: 52.00 (0.48%)
Spread: 4.00 (0.037%)
Open: 10,946.00
High: 11,018.00
Low: 10,858.00
Prev. Close: 10,862.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks slide as US Fed still hangs over markets

Fri, 18th Jun 2021 17:04

(Alliance News) - It was depressing end to the week for stocks in London, with the prospect of rising US interest rates adding to disappointing UK retail sales data.

"It's been a disappointing end to the week for stock markets in Europe, with the after effects from Wednesday's Fed decision still reverberating, wiping out any prospect of gains in a week that saw new record highs for both the DAX and Stoxx600," CMC Markets Chief Market Analyst Michael Hewson said.

He continued: "In what can only be described as choppy trading conditions, sentiment was given an additional knock this afternoon on the back of comments from St Louis Fed President James Bullard who said he was leaning towards a US rate rise in 2022, much sooner than Wednesday’s changed 'dots' of two by the end of 2023."

James Bullard, president of the Federal Reserve Bank of St Louis, told CNBC that "I think it's natural that we've tilted a little bit more hawkish here to contain inflationary pressures."

The remarks came after Fed officials on Wednesday moved up their forecasts for raising interest rates.

The FTSE 100 index closed down 135.96 points, or 1.9%, at 7,017.47 on Friday - the blue chip index lost 1.8% this week.

The mid-cap FTSE 250 index ended 210.95 points, or 0.9%, lower at 22,324.19 - resulting in the benchmark losing 1.9% over the past 5 days.

The AIM All-Share index closed down 0.9% at 1,229.80.

The Cboe UK 100 index closed down 2.0% at 698.26. The Cboe 250 ended down 1.2% at 20,021.46, and the Cboe Small Companies lost 1.0% at 15,199.94.

In mainland Europe, the CAC 40 in Paris gave back 1.5%, while the DAX 30 in Frankfurt ended down 1.8%.

IG's Chief Market Analyst Chris Beauchamp said: "Heavy losses in Europe and in the US are being influenced by options expiry but the second half of this week has taken on a distinctly 'risk off' feel, as investors seek to reassess a host of assumptions now that the Fed has changed its own working and outlook for the year for monetary policy.

"Having seemed so dedicated to the idea of 'transitory' inflation and talking markets down that path for so much of 2021 thus far the world's most powerful central bank appears to have shied away from the implications of such a policy and instead has gone back to the usual playbook of worrying about inflation. This could signal the start of a much more volatile period for markets, certainly over the summer until the Jackson Hole conference, so today could be just the opener to a much tougher few weeks for equities."

In the US, Wall Street was taking its cue from the dire European session, covered in red at the equities close in London. The Dow Jones Industrial Average was down 1.3%, the S&P 500 down 1.1% and the Nasdaq Composite 0.9% lower.

The dollar was improving on Friday evening, as investors seek safe-haven assets.

"Today is a day for safe haven assets, which at the present time just means the US dollar. Everyone is rushing to the greenback in the wake of the Fed meeting, and this dramatic change of the tides is making itself felt across a host of assets. Even the declines in EURUSD and GBPUSD do not appear to be doing much for European stock markets, and instead we have a classic 'flight to safety' that has been brewing for around 48 hours and is gathering pace as the weekend looms," IG's Beauchamp said.

The euro traded at USD1.1854 at the London equities close on Friday, down sharply on USD1.1920 late Thursday. Against the yen, the dollar fell to JPY110.26 versus JPY110.30.

Sterling was quoted at USD1.3799, tumbling from USD1.3933 at the London equities close on Thursday.

In London, blue chip banks were bearing the brunt of the move out of risk-assets. Barclays lost 3.9%, Lloyds gave back 3.2%, StanChart 3.4%, HSBC 2.3% and NatWest 1.7%.

"Banks have slipped back as short-term rates rise and longer-term rates come down, flattening the bond curve." Hewson explained.

Oil majors came under pressure, tracking the price of oil lower. Royal Dutch Shell 'A' shares closed down 3.1%, while the 'B' shares lost 4.0% and peer BP gave back 2.7%.

Brent oil was trading at USD73.56 a barrel, falling against USD74.06 late Thursday.

AstraZeneca welcomed a Brussels court decision over its vaccine supply pact with the EU.

The Anglo-Swedish pharmaceutical firm ended flat on Friday.

The European Commission President Ursula von der Leyen, meanwhile, welcomed that the decision confirmed its stance that Astra did not live up to its commitments.

The EU was looking to sue the London-listed pharmaceutical group in a bid to force it to deliver 90 million more doses of its Covid-19 vaccine before July. Astra delivered only 30 million doses in the first quarter out of the 120 million it was contracted to supply.

The Anglo-Swedish pharmaceutical firm on Friday said the European Commission had requested 120 million vaccine doses cumulatively by the end of this month, and a total of 300 million by the end of September.

The judge at the Court of First Instance in Brussels, however, has ordered delivery of just 80.2 million doses by September 27 - a figure Astra expects to "substantially exceed" by the end of June given it has already supplied more than 70 million doses to the EU.

Astra said it now looks forward to "renewed collaboration" with the EC.

In the midcaps, Inchcape ended the best performer, up 4.6%, as it guided to a full-year profit beat.

Since its first quarter update in late-April, Inchcape has seen "encouraging trends", the automotive distribution, retailing and services company noted.

"The group's performance to date has exceeded our expectations. During the period we have seen our businesses benefit both from an uptick in demand and margin resilience," it said.

Inchcape expects annual pretax profit, before exceptional items, to top consensus forecasts of GBP216 million, so at least a 68% hike from GBP128.9 million in 2020.

Retail sales volumes fell 1.4% month-on-month in May, pulling back after a 9.2% surge in April. Mid-April saw the re-opening of non-essential retail in England after months of lockdown. Consensus, according to FXStreet, had expected growth of 1.6% for May.

The largest contribution to May's decline came from food stores, the Office for National Statistics noted, where sales fell by 5.7%. Evidence suggests the easing of hospitality restrictions diverted some spending to pubs and restaurants after months of eating and drinking at home.

Alongside the UK retail sales data came first-quarter results from Tesco, the country's biggest supermarket chain. They showed a slowdown in sales growth.

Like-for-like retail sales for the 13 weeks to May 29 grew 1.0% year-on-year to GBP13.36 billion, and rose 8.1% on a two-year basis. For the financial year ended February, like-for-like sales growth was 6.3%.

In March 2020, UK supermarkets began to get a pandemic-related boost as consumers stockpiled and were forced to spend more time at home due to lockdown restrictions.

Tesco closed down 3.8%.

Gold was quoted at USD1,775.60 an ounce Friday evening, slipping from USD1,768.00 on Thursday.

The international calendar next week will be headlined by the Bank of England, with a rate decision due next Thursday. The UK, like other countries across the globe, is contending with gathering price pressures as the economy starts to bounce back from last year's bruising lockdowns.

Figures earlier this week showed UK annual inflation in May topped the BoE's 2% target for the first time in nearly two years. The consumer price index jumped 2.1% on an annual basis in May, accelerating from 1.5% growth in April, to mark the fastest growth since July 2019. The BoE targets a 2% inflation rate.

A busy Wednesday has flash PMI reading for France, Germany, the eurozone, UK and the US. On Friday, the US Fed's main inflation benchmark, personal consumption expenditures price index data is due. Also worth keeping an eye on next week is the Fed's latest results of its 2021 stress tests on the US banking system.

The local corporate calendar on Monday has full-year results from Brandshield Systems and SysGroup.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.